Parmax Pharma (540359)
TURNAROUNDScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹37.85 |
| Market Cap | ₹14.16 Cr |
| P/E Ratio | 0 |
| ROCE | -12.45% |
| ROE | 5,105.74% |
| Dividend Yield | 0% |
| Profit Growth | -87.18% |
| Debt/Equity | — |
| Sales Growth | -31.05% |
| 52-Week Range | ₹22.6 — ₹45.87 |
| Sector | Pharmaceuticals & Biotechnology |
Parmax Pharma trades with ROCE of -12.45%, ROE of 5,105.74%, profit growth of -87.18%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer